Lipella Pharmaceuticals Statistics
Total Valuation
LIPO has a market cap or net worth of $4.44 million. The enterprise value is $1.33 million.
| Market Cap | 4.44M |
| Enterprise Value | 1.33M |
Important Dates
The next estimated earnings date is Monday, May 13, 2024, before market open.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
LIPO has 6.25 million shares outstanding. The number of shares has increased by 47.84% in one year.
| Shares Outstanding | 6.25M |
| Shares Change (YoY) | +47.84% |
| Shares Change (QoQ) | +17.67% |
| Owned by Insiders (%) | 45.56% |
| Owned by Institutions (%) | 5.48% |
| Float | 3.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.97 |
| Forward PS | n/a |
| PB Ratio | 1.43 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.90, with a Debt / Equity ratio of 0.04.
| Current Ratio | 8.90 |
| Quick Ratio | 8.63 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -424.79 |
Financial Efficiency
Return on equity (ROE) is -150.10% and return on invested capital (ROIC) is -144.65%.
| Return on Equity (ROE) | -150.10% |
| Return on Assets (ROA) | -127.20% |
| Return on Capital (ROIC) | -144.65% |
| Revenue Per Employee | $89,923 |
| Profits Per Employee | -$923,793 |
| Employee Count | 5 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.53% in the last 52 weeks.
| Beta (1Y) | n/a |
| 52-Week Price Change | -62.53% |
| 50-Day Moving Average | 0.81 |
| 200-Day Moving Average | 1.31 |
| Relative Strength Index (RSI) | 44.22 |
| Average Volume (30 Days) | 61,516 |
Short Selling Information
The latest short interest is 43,697, so 0.70% of the outstanding shares have been sold short.
| Short Interest | 43,697 |
| Short Previous Month | 53,077 |
| Short % of Shares Out | 0.70% |
| Short % of Float | 1.16% |
| Short Ratio (days to cover) | 0.34 |
Income Statement
In the last 12 months, LIPO had revenue of $449,617 and -$4.62 million in losses. Loss per share was -$0.77.
| Revenue | 449,617 |
| Gross Profit | 449,617 |
| Operating Income | -4.75M |
| Pretax Income | -4.62M |
| Net Income | -4.62M |
| EBITDA | -4.61M |
| EBIT | -4.61M |
| Loss Per Share | -$0.77 |
Balance Sheet
The company has $3.29 million in cash and $136,594 in debt, giving a net cash position of $3.16 million or $0.51 per share.
| Cash & Cash Equivalents | 3.29M |
| Total Debt | 136,594 |
| Net Cash | 3.16M |
| Net Cash Per Share | $0.51 |
| Equity / Book Value | 3.14M |
| Book Value Per Share | 0.50 |
| Working Capital | 3.04M |
Cash Flow
In the last 12 months, operating cash flow was -$3.15 million and capital expenditures -$14,434, giving a free cash flow of -$3.16 million.
| Operating Cash Flow | -3.15M |
| Capital Expenditures | -14,434 |
| Free Cash Flow | -3.16M |
| FCF Per Share | -$0.53 |
Margins
Gross margin is 100.00%, with operating and profit margins of -1,055.55% and -1,027.31%.
| Gross Margin | 100.00% |
| Operating Margin | -1,055.55% |
| Pretax Margin | -1,027.31% |
| Profit Margin | -1,027.31% |
| EBITDA Margin | -1,024.52% |
| EBIT Margin | -1,024.90% |
| FCF Margin | -703.84% |
Dividends & Yields
LIPO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -47.84% |
| Shareholder Yield | -47.84% |
| Earnings Yield | -103.00% |
| FCF Yield | -70.57% |
Analyst Forecast
The average price target for LIPO is $2.00, which is 179.72% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $2.00 |
| Price Target Difference | 179.72% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LIPO has an Altman Z-Score of -0.93 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.93 |
| Piotroski F-Score | 4 |